Ozempic maker Novo Nordisk hit by cyberattack, hackers threaten to sell stolen data

Novo Nordisk, maker of diabetes and weight-loss drugs Ozempic and Wegovy, has been targeted in a major cyberattack. Cyber extortion group FulcrumSec claimed it stole over 1.3 terabytes of company data after spending more than two months inside Novo Nordisk's systems, Reuters reported. The group said it demanded $25 million and may sell the data after its demand was rejected.